|Day Low/High||307.18 / 312.48|
|52 Wk Low/High||263.30 / 380.76|
When stock fundamentals and stock valuations diverge, profit opportunities are created.
ILMN shares were down about 15% in Friday trading after they pre-announced a revenue miss for its second quarter.
To effectively generate profits, a trader must pick several companies in a sector and short the whole bunch.
Ark Invest has developed a series of specialized exchange-traded funds that own shares in companies involved in 'disruptive innovation.'
Experts offer their top stock ideas in oncology detection and treatment.
PepsiCo, GE and just like the weather, the stock market is subject to change.
Straying from these names could land you in quicksand as the 4th quarter begins.
Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.
It is all about perception, and here are strong names to pick up on market weakness.
Look for gains in Illumina shares to $300 and then perhaps around $340.
The crash of oil will only accelerate the move.
Watch for these upstart names to topple some big-caps going forward.
It's hard to understand the magnitude of the change.
You can make a case to buy any of the stocks of the companies at ICR.
These lesser-known diagnostic and life sciences firms are involved in areas from genetic tools to telemedicine.
Slow markets like this demand a less-is-more approach.
It's a wonder to me how split this market really is.
Nike, Apple, Illumina and Facebook take the last four spots in TheStreet's Market Bracket Challenge.
This week's introduction of the NovaSeq Series of genomic sequencers caused the stock to jump.